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Abstract
Background: Increases during aging in extracellular levels of glutamate (Glu), the major excitatory neurotransmitter in 
the brain, may be linked to chronic neurodegenerative diseases. Little is known about the molecular responses of 
neurons to chronic, moderate increases in Glu levels. Genome-wide gene expression in brain hippocampus was 
examined in a unique transgenic (Tg) mouse model that exhibits moderate Glu hyperactivity throughout the lifespan, 
the neuronal Glutamate dehydrogenase (Glud1) mouse, and littermate 9 month-old wild type mice.
Results: Integrated bioinformatic analyses on transcriptomic data were used to identify bio-functions, pathways and 
gene networks underlying neuronal responses to increased Glu synaptic release. Bio-functions and pathways up-
regulated in Tg mice were those associated with oxidative stress, cell injury, inflammation, nervous system 
development, neuronal growth, and synaptic transmission. Increased gene expression in these functions and 
pathways indicated apparent compensatory responses offering protection against stress, promoting growth of 
neuronal processes (neurites) and re-establishment of synapses. The transcription of a key gene in the neurite growth 
network, the kinase Ptk2b, was significantly up-regulated in Tg mice as was the activated (phosphorylated) form of the 
protein. In addition to genes related to neurite growth and synaptic development, those associated with neuronal 
vesicle trafficking in the Huntington's disease signalling pathway, were also up-regulated.
Conclusions: This is the first study attempting to define neuronal gene expression patterns in response to chronic, 
endogenous Glu hyperactivity at brain synapses. The patterns observed were characterized by a combination of 
responses to stress and stimulation of nerve growth, intracellular transport and recovery.
Background
Glutamate (Glu) is the major excitatory neurotransmitter
in the mammalian brain. Glu is released from nerve cell
processes following electrical excitation, interacts with
surface receptors in the synaptic region of another nerve
cell, and initiates the influx of sodium and calcium ions
across the membrane of the post-synaptic neuron. Such
ion fluxes produce a change in the electrical properties of
the post-synaptic nerve cell (sodium flux), as well as
changes in intracellular signalling cascades that lead to
altered gene expression (calcium entry) [1]. Thus, in addi-
tion to the rapid form of neuron-to-neuron communica-
tion through the actions of Glu as a transmitter, Glu also
acts as a signalling molecule with long-lasting effects on
neuronal structure and function. Glu neurotransmission
is an important component of the modification of synap-
tic activity that is associated with the acquisition and
storage of new information, i.e., learning and memory
formation [2-4], and of the normal development of the
nervous system [1,5,6].
Despite the multiple beneficial actions of Glu in the
central nervous system (CNS) of mammals, it is also true
that excessive excitation of neurons by Glu can lead to
nerve cell damage and neurological dysfunction [7]. The
consequences of hyper-excitation by Glu are swelling of
the neuronal cell body and dendrites, destruction of
organelles, and, ultimately, cell death [8]. It was proposed
that pathological states in the CNS may result from either
acute or chronic excessive release of Glu and over-activa-
tion of its post-synaptic receptors [9-13]. This suggestion
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is based, primarily, on the toxicity that follows acute
exposure of nerve cells to excessive excitation by Glu.
But, as we pointed out previously [14], acute treatments
with Glu may not fully replicate the effects of chronic,
localized, moderate excess release of Glu at synapses
occurring throughout the lifespan of an organism.
To probe the effects of excess extracellular Glu concen-
trations in the brains of living organisms, three animal
models were developed previously. The first two animal
models are the null mutant mice for Glu transporters
Slc1a2 (Eaat2 or Glt-1) and Slc1a3 (Eaat1 or Glast), and
the third is a knockout for the tuberous sclerosis com-
plex-1 gene (Tsc1) [15-18]. Both the Slc1a2 and Tsc1 null
m u t a n ts  h a v e  l os s  o f  fu n c t i o n  o f  G l u  t r a n s po rt e r s  a n d
accumulate a large excess of Glu in the extracellular
medium (1.5 to 32-fold normal levels) [16-18]. Since the
Glu transporters are indispensable for normal brain
development and function, knocking out two transporter
genes in a mouse leads to excessive brain damage and
embryonic lethality [15]. Knocking out either a single
transporter gene, or the Tsc1  gene which affects the
expression and function of Glu transporters, leads to dra-
matic reductions in the life span of the mutant mice
(lifespan of 3-4 months) [16-18]. Based on these observa-
tions, it is clear that none of these mutant mice would be
a good model for probing the effects of moderate, tran-
sient increases in extracellular Glu on neurons through-
out the lifespan of an organism.
Recently, we have developed a transgenic (Tg) mouse
model of chronic, moderate excess release of Glu in CNS
synapses [14]. Using this model, we have shown that such
release can decrease the number of synapses on nerve cell
processes and suppress the electrical activation of such
synapses in a physiological model of memory formation
[14]. To achieve excess Glu formation in neurons and
increased release from synaptic terminals in these ani-
mals, the gene for the enzyme glutamate dehydrogenase 1
(Glud1) was introduced under the control of the pro-
moter for neuron-specific enolase (Nse), thus its over-
expression occurs only in neurons [14]. Despite the
increases in depolarization induced Glu release from
nerve terminals, neuronal and synaptic losses were
observed only in select populations of nerve cells. As sim-
ilar changes in synaptic function and losses of select Glu-
responsive neurons occur during normal brain aging and
in neurodegenerative diseases, such as Alzheimer's dis-
ease [19-21], this line of Tg mice appeared to be a good
model to study the transcriptomic effects of chronic Glu
hyperactivity at synapses in order to begin to define the
possible associated cell and molecular compensatory
mechanisms to continuous, life-long, hyperactivity by the
Glu-releasing neurons.
The neurons of the Glud1 Tg mice would be expected
to make numerous transcriptomic changes in order to
either adapt, compensate, or correct the disequilibrium of
excess synaptic Glu stimulation during the lifetime of
these animals. In addition to the increases in Glu release,
the Glud1 mice may also be exposed to altered intracellu-
lar metabolic states as a result of the over-expression of
the mitochondrial enzyme GLUD1. The genes whose
expression would be significantly altered in Glud1 mice
compared with age-matched wild type (wt) animals, and
the molecular pathways and cellular functions that they
represent, may help unravel the most substantial neu-
ronal responses to the over-expression of Glud1 and the
exposure of cells to excess Glu stimulation. In the present
study, we present a detailed analysis of genome-wide
expression differences between nine month-old Glud1
and wt mice. This analysis revealed mechanistic insights
into the types of molecular functions, neurobiological
pathways and gene-gene interactions that might influ-
ence the responses of CNS neurons to increased Glud1
mitochondrial activity and of neurons and glial cells to
chronic, moderate excess of synaptic Glu release.
Results and Discussion
Changes in genomic transcription in hippocampal cells of 
Glud1 Tg mice
Comparative genome-wide transcriptional analyses of Tg
and wt mice were performed on the hippocampus region
of the brain of these animals. The rationale for the selec-
tion of this region for this study was two-fold: 1) the pre-
dominant neurotransmitter in the hippocampus is Glu;
and 2) it is one of the brain regions in which clear struc-
tural and physiological changes were detected in the Tg
mice [14]. The differences between Glud1 and wt mouse
hippocampi included increases in synaptic Glu release,
decreased long term potentiation of synaptic activity fol-
lowing high frequency stimulation of neurons, decreased
number of dendritic processes (the receptive zones of
neurons for incoming synaptic signals), decreased synap-
tic sites on dendrite protrusions (the dendrite spines),
and decreased number of nerve terminals that form such
synapses. Furthermore, the hippocampal region is partic-
ularly vulnerable to aging and neurodegenerative dis-
eases, and this vulnerability may result from chronic Glu
hyperactivity in this brain region [21].
Nine mo-old Glud1 Tg mice were used in the study of
whole genome gene expression. When compared to wt
mice of the same age, Glud1 mice at this age exhibit some
initial signs of neuronal loss and damage to their den-
drites and nerve terminals, but not as extensive as those
observed at older ages (e.g., 20 mo-old) [14]. Thus, at the
age of nine months it would be possible to probe for
changes in gene expression that may represent adaptive,
compensatory or corrective responses of hippocampus
cells to chronic Glu hyperactivity, while at the same timeWang et al. BMC Genomics 2010, 11:360
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minimizing the impact of neuronal death on the results of
gene array analyses.
A distinct transcriptional profile was found in Glud1 Tg
mice as compared with that of wt animals. Analysis of the
microarray data using condition tree revealed two dis-
tinct clusters, one corresponding to the group of Glud1
mice and the other to that of wt mice. This observation
supported the idea that neurons and glia in the brains of
the Glud1 Tg mice were responding to the chronic over-
expression of Glud1 in neurons by exhibiting a different
pattern of DNA transcription than that seen in wt mice.
Using the Affymetrix GeneChip Mouse Genome 430
2.0 array that contains 45,037 probesets of over 39,000
transcripts, a total of 1,018 probesets were identified as
being significantly altered in Glud1  Tg mice. Among
these differentially expressed probesets, 707 were more
highly expressed in Tg than wt mice (up-regulated), and
311 showed the opposite pattern (down-regulated) (Fig-
ure 1A). Some of the prominent up- or down-regulated
genes in Glud1 T g mice are shown in Additional file 1,
with the complete list of differentially expressed probe-
sets available in Additional file 2. Of the 1,018 differen-
t i a l l y  e x p r e s s e d  p r o be s e t s,  o n l y  9  w e r e  e x pec t e d  t o  be
false positives, i.e., the false discovery rate (FDR) was
0.9%.
Transcriptomic changes in neurobiological processes, 
functions, and pathways in response to Glud1 over-
expression
To uncover neurobiological and cellular processes that
were significantly altered in Glud1 mouse hippocampus,
we first carried out Gene Ontology (GO) analyses on the
up- or down-regulated genes identified above. The GO
biological processes that were significantly enriched in
up-regulated genes in Glud1  m i c e  c o m p a r e d  w i t h  w t
mice are shown in Figure 1B, while those that were
enriched in down-regulated genes are shown in Figure
1C. The specific genes within the GO categories shown in
Figure 1B and 1C, are listed in Table 1. As shown in Fig-
ure 1B and 1C, as well as in Table 1, there were eight cate-
gories of biological processes that were significantly
enriched in up-regulated genes and six GO categories sig-
nificantly enriched in down-regulated genes in Glud1
mice. Among these categories, four (Nervous system
development, Intracellular signal transduction, Synaptic
neurotransmission, and Ion homeostasis) were enriched in
both up- and down-regulated genes (Figure 1B, C; Table
1), with the up-regulated genes in Glud1 mice outnum-
bering those that were down-regulated in the respective
categories. Four of the other GO categories were
enriched only in up-regulated genes in T g mice. These
four categories were: mRNA processing, Protein mis-fold-
Figure 1 Enrichment analysis of functional groups of up- and down-regulated genes associated with chronic glutamate hyperactivity. (A) 
Approximately 2% of the over 39,000 gene transcripts surveyed by Affymetrix Mouse Genome 430 2.0 Array were identified to be significantly up-
regulated, and 1% to be down-regulated, with an FDR of 0.9%. (B, C) Gene Ontology (GO) analysis of up- (B) and down-regulated (C) biological pro-
cesses associated with chronic glutamate hyperactivity. This analysis was conducted with GO-elite using hypergeometric distribution. A Z score > 1.96 
or < -1.96 and a permute P value < 0.05, were considered to be statistically significant. (D, E) Comparative analyses of over-represented bio-functions 
and canonical pathways, respectively, in up- and down-regulated genes using Ingenuity Pathway Analysis (IPA). Significance calculated by IPA was 
plotted as -log P value and the dashed line corresponds to the threshold P = 0.05.Wang et al. BMC Genomics 2010, 11:360
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ing correction and degradation,  Cytoskeleton and focal
adhesion, and Cognition and behavior (Table 1).
Comparative bio-function analysis between Tg and wt
mouse hippocampus genes was also performed using the
Ingenuity Pathway Analysis (IPA) software. Major bio-
functions significantly enriched in up- or down-regulated
genes in Tg mice are shown in Figure 1D and are listed in
Additional file 3. Of the eleven bio-functions, six were
enriched in both up- and down-regulated genes in Tg
mice, and five were enriched only in up-regulated genes
in the Glud1 mice. In addition, the statistical significance
values (shown as -Log P) for up-regulated genes were sig-
nificantly greater than those for the down-regulated
Table 1: Genes associated with the Gene Ontology (GO) biological processes shown in Figure 1B and 1C
GO Biological Processes Associated Genes
A) Up-regulated GO biological processes
Nervous system development (70 
genes)
Actr3, Acvr1, Ank3, Apc, Aplp2, Arc, Arhgef2, Arpc2, Atp2b2, Atrx, B3gnt2, Bcl11b, Brsk2, Btg2, 
Cacna1c, Centb2, Cttn, Diap1, Dpysl2, Egr2, Elavl3, Enah, Epha3, Epha4, Epha6, Epha7, Fos, Fut8, 
Gja1, Grin2a, Hipk2, Itga8, Kif5c, Klhl24, Lefty1, Mbp, Mef2a, Mib1, Ndel1, Ndst1, Nfib, Nisch, Npnt, 
Nrcam, Nrp1, Nrp2, Nrxn3, Ntrk2, Ntrk3, Pafah1b1, Pbx1, Pcsk2, Pex2, Prkca, Prkg1, Ptk2, Rsc1a1, 
Rtn4, Scn2a1, Scn8a, Sema5a, Sh3rf1, Slit3, Tacc1, Top2b, Trpm7, Wasl, Yy1, Zbtb16, Zeb2
Intracellular signal transduction (68) Aak1, Abl2, Acvr1, Add1, Add2, Akt3, Aplp2, Arhgef12, Arhgef2, Atp2b2, Brap, Brsk2, Camk2a, 
Camk2b, Centb2, Centg2, Csnk1a1, Diap1, Dock10, Dock9, Dyrk1a, Epha3, Epha4, Epha6, Epha7, 
Fert2, Frap1, Fut8, Hipk2, Hrasls, Itga8, Kalrn, Ksr1, Map2k4, Mapk14, Mapk8, Mtmr1, Mtmr3, 
Mtmr9, Myo9b, Ndst1, Net1, Nisch, Npnt, Nrp1, Ntrk2, Ntrk3, Pafah1b1, Pftk1, Phip, Phka2, Ppp3ca, 
Prkca, Prkg1, Ptk2, Ptk2b, Ptprj, Ptprs, Rabgap1, Rps6kb1, Rutbc3, Slc8a2, Slk, Srpk2, Tbc1d15, Tlk2, 
Trpm7, Uhmk1
Cytoskeleton & focal adhesion (38) Abl2, Actr3, Add1, Add2, Apc, Arc, Arhgef2, Arpc2, Cap2, Capn3, Centb2, Clasp1, Clip1, Coro1c, 
Diap1, Dmd, Dst, Enah, Enc1, Epb4.1l1, Frmd4b, Gmfb, label, Mtap7, Myo9b, Ndel1, Nisch, 
Pafah1b1, Polb, Ptk2, Ptk2b, Spire1, Tacc1, Tpm1, Trpm7, Wasf3, Wasl, Wdr1
Ion transport & homeostasis (23) Atp1a1, Atp2b2, Atp2c1, Atp6v0d1, Atp8a1, Atp9b, Cacna1c, Cacna1d, Cacna1h, Cacna2d1, 
Cacnb2, Camk2a, Camk2b, Grin2a, Grin2b, Ppp3ca, Ryr1, Scn2a1, Scn3b, Scn8a, Slc8a2, Trpc4, 
Trpm7
Synaptic neurotransmission (21) Arc, Atp2b2, Atxn1, Camk2a, Dlg1, Dlg2, Dlg4, Erc2, Exoc4, Exoc5, Gabbr1, Gabrb2, Gabrb3, Grin2a, 
Grin2b, Magi2, Nrxn3, Ppp3ca, Rps6kb1, Snca, Vps33a
mRNA processing (15) Adar, Cdc40, Cpsf6, Cugbp2, Lsm11, Prpf39, Prpf40a, Sfpq, Sfrs10, Sfrs12, Sfrs8, Srpk2, Srrm2, 
Syncrip, Tra2a
Protein mis-folding correction & 
degradation (9)
Ahsa1, Ahsa2, Dnajc1, Usp12, Usp19, Usp20, Usp32, Usp47, Usp7
Cognition & behavior (8) Atxn1, Cacna1c, Epha4, Grin2a, Grin2b, Itga8, Pafah1b1, Scn8a
B) Down-regulated GO biological processes
Intracellular signal transduction (57) AW551984, Acvr2b, Adra2a, Angpt1, Anxa1, Arhgap6, Bmper, Cacnb4, Calca, Car8, Cckbr, Cd24a, 
Cdc42ep1, Cit, D0H4S114, Dcx, Ddit4l, Ddr2, Depdc6, Gnb4, Gng4, Gpr101, Gpr103, Gpr83, Gulp1, 
Hrh1, Igf1, Khdrbs1, Nr2f2, Pde1c, Pde9a, Pgr, Plcxd3, Plek, Ppard, Ptprd, Rab3b, Reln, Rfxank, Rgs17, 
Rgs2, Rora, Rspo2, Sh2d3c, Shd, Slc9a3r2, Sparc, Stmn1, Tacr3, Tbc1d8, Tgm2, Timp2, Trhr, Unc13c, 
Unc5d, Wnt4, Wnt7a
Gene transcription (33)  6430502M16Rik, Ankrd56, Arx, Btbd11, Cutl1, Cutl2, Etv6, Foxp2, Hes5, Hivep1, Hoxc6, Ikzf4, Irf6, 
Khdrbs1, Klf5, Lbh, Ldb2, Lhx2, Maf, Mef2c, Mrg1, Nr2f2, Pbx3, Pgr, Ppard, Prrx1, Rora, Satb1, Satb2, 
Ssbp2, Trim66, Tshz2, Tshz3
Nervous system development (29) Arx, Atp1a2, Calca, Car10, Cd24a, Cd44, Cit, Cobl, Cutl1, Dcx, Efna5, Foxp2, Gap43, Grin3a, Hes5, 
Igf1, Lhx2, Nr2f2, Nts, Pex13, Pgr, Ppard, Reln, Rora, Stmn1, Timp2, Tnnt2, Wnt4, Wnt7a
Cell adhesion & secretion (14) Amn, Anxa1, Cacnb4, Calca, Cd24a, Cplx3, Cutl1, Exoc6, Ppard, Rab3b, Rims3, Tgm2, Unc13c, 
Wnt7a
Synaptic neurotransmission (10) Atp1a2, Cacnb4, Cckbr, Cplx3, Gpr103, Gpr83, Rims3, Slc17a6, Tacr3, Wnt7a
Ion homeostasis (4) Atp1a2, Cacnb4, Calca, Cd24aWang et al. BMC Genomics 2010, 11:360
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genes in bio-functions populated by both up- and down-
regulated genes in Glud1 mice (Figure 1D).
As indicated in Figure 1D, the bio-functions identified
by the IPA analysis were similar to the biological pro-
cesses identified by the GO analysis, including Cell sig-
nalling,  Nervous system development,  RNA post-
transcriptional modification and RNA trafficking, Behav-
ior, Cellular assembly and organization, and Molecular
transport. The genes in these bio-functions (Additional
file 3) were, for the most part, the same genes identified
by the GO analysis (Table 1). Bio-functions identified by
the IPA analysis but not by the GO analysis included
those of Amino acid metabolism, Cell death, Organismal
survival, and DNA replication, recombination, and repair
(Figure 1D and Table 2).
IPA analysis was also used to determine canonical bio-
logical pathways that were significantly enriched with
either up- or down-regulated genes in Glud1 compared
with wt hippocampus cells. Eleven pathways were identi-
fied (Figure 1E and Additional file 4). Use of the IPA
canonical pathway analysis led to the identification of
some biological pathways that did not relate to either the
categories of biological processes identified by means of
the GO analysis or to the bio-functions identified by IPA.
Y et, some of these pathways were enriched with genes
that were components of either GO categories or IPA-
identified bio-functions, such as Axonal guidance signal-
ling,  Calcium signalling,  Ephrin receptor,  Synaptic long
term potentiation, Integrin signalling, and Neurotrophin/
TRK signalling (Additional file 4). But, several of the
pathways identified by IPA analysis provided new infor-
mation into the effects of chronic Glud1 over-expression
and mild Glu hyperactivity on hippocampal neurons that
was not uncovered by the GO or IPA bio-function analy-
ses (Table 2). These pathways were Huntington's disease
signalling, Chemokine signalling, NRF2-mediated oxida-
tive stress response,  Neuregulin signalling, and Toll-like
receptor signalling (Figure 1E and Table 2).
Overall, the GO and IPA analyses identified some key
biological and neurobiological processes, functions and
pathways that appeared to be altered in Glud1 mice pri-
marily through gene up-regulation. Looking at these cate-
gories in their totality, it would appear that hippocampal
cells in the T g mice were under some level of stress to
which they responded by activating intracellular signals
(Intracellular signal transduction and Cell signalling), sig-
nals that may lead to cell protection from damage or
death (Protein mis-folding correction & degradation and
Cell death), signals that are associated with inflammatory
responses and cell survival (Chemokine signalling and
Toll-like receptor signalling), and signals that mediate
responses to oxidative stress (NRF2-mediated oxidative
stress response) .  I n  a d d i t i o n  t o  t h e  s i g n a l l i n g  p a t h w a y s
enumerated above, there was also a signalling pathway
related to a severe neurological disorder, the Huntington's
disease signalling pathway.
Huntington's disease signalling pathway
This pathway was most significantly enriched with up-
regulated genes in the Glud1 mice (Figure 1E). Hunting-
ton's disease is an autosomal dominant hereditary neuro-
logical disorder caused by an expansion of triplet repeats
in the gene for the protein Huntingtin. Huntington's dis-
ease does not usually affect hippocampal neurons, there-
fore, the enhanced expression of genes in this pathway in
Glud1 mice may be a reflection of molecular processes
that are potentially related to the cause or the progression
of the disease. A current view of the molecular and cellu-
lar defects associated with this disease is that the abnor-
mal Huntingtin protein leads to changes in vesicle
trafficking in neurons [22]. Among the genes up-regu-
lated in the Glud1 mice was Snca (Alpha-Synuclein), a
protein involved in neurotransmitter (dopamine) release
from nerve terminals and in the integration of signal
transduction and membrane vesicle trafficking at nerve
terminals. Some of the other up-regulated genes in the
Huntington's disease signalling pathway included the gene
Ap2a2 (Adaptor Protein Complex AP-2, Alpha 2 Subunit;
also known as Huntingtin-Interacting Protein J). The
AP2A2 protein, together with Huntingtin, interacts with
the protein Clathrin in the process of endocytosis of
membrane vesicles [23]. Another significantly up-regu-
lated gene in the same pathway, Gosr1, encodes a member
protein of the soluble N-Ethylmaleimide-Sensitive Factor
Attachment Protein Receptor (SNARE) complex that
links endocytic vesicles to the trans-Golgi network in
cells [24]. Finally, Napg  (N-Ethylmaleimide Sensitive
Fusion Protein Attachment Protein Gamma), important
in vesicle trafficking in cells [25], was also an up-regu-
lated gene in Tg mice. Thus, it appeared that hippocam-
pal neurons responded to excess expression of Glud1 and
activation of Glu neurotransmission by up-regulating
several genes related to vesicular trafficking, genes that
are also part of the Huntington's disease pathway.
Intracellular signal transduction
Examples of genes involved in intracellular signal trans-
duction related to stress and to either apoptosis or cell
survival included the genes for two stress kinases, c-Jun
N-terminal Kinase (Mapk8) and p38 MAP Kinase
(Mapk14), the gene for an anti-apoptotic protein that
protects neurons from Glu-induced apoptosis, Myocyte
Enhancer Factor 2a (Mef2a) [26], the gene for a member
of the mitochondrial heat shock factor 40 protein family
(Dnaja3, DnaJ [Hsp40] Homolog, Subfamily A, Member
3) with both pro-apoptotic and cell survival-enhancing
functions [27], and the gene for a protein that affects
brain development and neuronal survival and differentia-
tion, the Dual Specificity Tyrosine-Phosphorylation Reg-
ulated Kinase 1a (Dyrk1a) [28]. As indicated, some of theWang et al. BMC Genomics 2010, 11:360
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Table 2: Genes associated with IPA bio-functions and canonical pathways that are different from the GO categories shown 
in Table 1
Bio-Functions Associated Genes
Molecular Transport
Up-regulated genes (41) Anp32a, Atp1a1, Atp2b2, Atp2c1, Atxn1, Cacna1c, Cacna1d, Cacna1h, Cacna2d1, Cacnb2, Camk2a, 
Camk2b, Erc2, Frap1, Gja1, Gnaq, Gpam, Grin2a, Grin2b, Htr1a, Kcna6, Kcnd2, Kcnip2, Kcnq1, Kcnq2, Lyk5, 
Nrxn3, Ntrk2, Ppp3ca, Ptk2, Rgs14, Ryr1, Scd, Scn2a, Scn8a, Smg6, Snca, Trpc4, Trpm7, Uhmk1, Ywhae
Down-regulated genes (18)  Adra2a, Atp1a2, Calca, Camk2d, Cast, Cav2, Cckbr, Dcn, Gap43, Igf1, Igfbp3, Nts, Rgs2, Satb1, Slc17a6, Trhr, 
Vip, Wnt7a
Cellular Assembly and 
Organization
Up-regulated genes (100) Actb, Adam17, Add1, Ank3, Anp32a, Ap2a2, Apc, Arf3, Arhgef12, Arhgef2, Arpc2, Atp2b2, Atp2c1, Bcl11b, 
Bin1, Cacna1c, Cacnb2, Camk2a, Cap2, Capn10, Centb2, Centg2, Clasp1, Clip1, Coro1c, Cttn, Diaph1, Dlg1, 
Dlg4, Dmd, Dnaja3, Dpysl2, Dsp, Dst, Eif4a1, Eif4e, Enah, Enc1, Epha4, Erc2, Exoc5, Frap1, Gas7, Gja1, Gnaq, 
Gng2, Gosr1, Gpm6a, Grin2a, Grip1, Htr1a, Itga8, Junb, Kalrn, Kcnq1, Klf2, Kpnb1, Ksr1, Map2, Map7, 
Mapk14, Mapk8, Mbp, Myo9b, Napg, Nav1, Ncam1, Ndel1, Neo1, Net1, Nfia, Nisch, Nmt1, Nrcam, Nrp1, 
Ntrk2, Ntrk3, Pafah1b1, Pex5l, Picalm, Prkg1, Psap, Ptk2, Ptk2b, Reps1, Rictor, Rims1, Rps6kb1, Rtn4, Sec24b, 
Sema5a, Slit3, Snca, Spire1, Top2b, Tpm1, Trpc4, Wasf3, Wasl, Ywhaz
Down-regulated genes (26) Cacnb4, Calca, Cast, Cav2, Cd24, Cd44, Cdc42ep1, Cdh13, Cit, Cntn4, Ctgf, Dcx, Efna5, Gap43, Grin3a, Igf1, 
Igfbp3, Klf5, Nts, Ppard, Reln, Rgs2, Sdc2, Sparc, Stmn1, Wnt7a
Amino Acid Metabolism
Up-regulated genes (35) Acvr1, Acvr2a, Akt3, B3gnt2, Brsk2, Btg2, Camk2a, Camk2b, Col4a3bp, Csnk1a1, Dusp6, Dyrk1a, Fer, Frap1, 
Gmfb, Hipk2, Kalrn, Large, Lyk5, Mapk14, Mapk8, Mtmr3, Ndst1, Phka2, Ppp3ca, Prkca, Prkg1, Ptk2b, Ptprd, 
Ptprj, Rps6kb1, Srpk2, St6galnac3, Tlk2, Trpm7
Down-regulated genes (6)  Ass1, Igf1, Igfbp3, Nts, Reln, Slc17a6
Cell Death
Up-regulated genes (99) Acvr1, Akt3, Aldh2, Ap2a2, Apc, Arc, Atf2, Atf6, Atp1a1, Atp2c1, Atrx, Atxn1, Bclaf1, Bin1, Btg2, Cacna1c, 
Cacnb2, Calb1, Camk2a, Capn10, Chka, Csnk1a1, Dmd, Dnaja3, Dsp, Dusp6, Egr1, Egr2, Eif4e, Fem1b, Fer, 
Fos, Frap1, Fubp1, Fus, Gabbr1, Gja1, Gmfb, Gnaq, Gng2, Grin2a, Hdac2, Hipk2, Hpca, Junb, Klf2, Ksr1, Lrig1, 
Map2k4, Mapk14, Mapk8, Mbp, Mef2a, Mgat3, Ncam1, Ndel1, Ndst1, Nptx1, Nr4a1, Nrcam, Nrf1, Nrp1, 
Ntrk2, Ntrk3, Pafah1b1, Phip, Polb, Ppp1r13b, Ppp3ca, Prkca, Psap, Ptk2, Ptk2b, Rad23b, Rasgrp1, Rbm5, 
Rps6kb1, Rraga, Rtn4, Scn2a, Scn3b, Sh3rf1, Ski, Slk, Snca, Tacc1, Tfrc, Tnfrsf25, Tnks2, Tpm1, Ube2k, Ubtf, 
Usp7, Vps33a, Ywhae, Yy1, Zbtb16, Zeb2, Zfr
Down-regulated genes (37)  Acvr2b, Angpt1, Anxa1, Atp1a2, Calca, Camk2d, Casp1, Cast, Cd24, Cd44, Cit, Ctgf, Dcn, Ecop, Etv6, Gulp1, 
Hoxc6, Igf1, Igfbp3, Igfbp6, Klf5, Mef2c, Nedd9, Phlda1, Plagl1, Ppard, S100a10, Satb1, Sdc2, Sparc, Stmn1, 
Tgm2, Timp2, Tmsb10, Vip, Wnt7a, Wwox
Organismal Survival
Up-regulated genes (44) Adar, Akt3, Apc, Aplp2, Cacnb2, Dmd, Dnaja3, Dsp, Dyrk1a, Egr2, Enah, Fus, Fut8, Gabrb3, Gja1, Gnaq, 
Grip1, Hapln1, Hipk2, Klf2, Magi2, Map2k4, Mapk14, Mapk8, Mef2a, Nfia, Nrf1, Nrp1, Ntrk2, Ntrk3, Pbx1, 
Pnpla6, Polb, Prkca, Ptk2, Ptprs, Rad23b, Ski, Spred2, Top2b, Wasl, Wdr1, Yy1, Zfr
RNA Trafficking
Up-regulated genes (3) Eif3a, Eif4a1, Eif4e
DNA Replication, 
Recombination, and Repair
Up-regulated genes (13) Atf2, Atp1a1, Fos, Gnaq, Gng2, Iqgap2, Kpnb1, Mapk8, Myo9b, Ptk2, Ptk2b, Ubtf, Yy1
Canonical Pathways Associated Genes
 Huntington's Disease 
Signalling
Up-regulated genes (Total 
number: 17)
Akt3, Ap2a2, Atf2, Capn10, Capn3, Dlg4, Frap1, Gnaq, Gng2, Gosr1, Grin2b, Hdac2, Map2k4, Mapk8, Napg, 
Prkca, Snca
Down-regulated genes (5) Casp1, Gng4, Igf1, Pik3r5, Tgm2
Axonal Guidance SignallingWang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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Up-regulated genes (23) Adam17, Akt3, Arhgef12, Arpc2, Dpysl2, Eif4e, Epha3, Epha4, Epha6, Epha7, Gnaq, Gng2, Kalrn, Nrp1, Ntrk2, 
Ntrk3, Ppp3ca, Prkca, Ptk2, Rtn4, Sema5a, Slit3, Wasl
Down-regulated genes (10) Arhgef15, Efna5, Gng4, Igf1, Pik3r5, Sdc2, Sema4a, Unc5d, Wnt4, Wnt7a
Chemokine Signalling
Up-regulated genes (9) Camk2a, Camk2b, Fos, Gnaq, Mapk14, Mapk8, Prkca, Ptk2, Ptk2b
Down-regulated genes (1) Camk2d
Ephrin Receptor Signalling
Up-regulated genes (14) Akt3, Arpc2, Atf2, Epha3, Epha4, Epha6, Epha7, Gnaq, Gng2, Grin2a, Grin2b, Kalrn, Ptk2, Wasl
Down-regulated genes (6) Angpt1, Arhgef15, Efna5, Gng4, Sdc2, Sh2d3c
 Synaptic Long Term 
Potentiation
Up-regulated genes (9) Atf2, Cacna1c, Camk2a, Camk2b, Gnaq, Grin2a, Grin2b, Ppp3ca, Prkca
Down-regulated genes (2) Camk2d, Grin3a
Integrin Signalling
Up-regulated genes (12) Actb, Akt3, Arf3, Arpc2, Capn10, Capn3, Itga8, Map2k4, Mapk8, Ptk2, Tspan5, Wasl
NRF2-mediated Oxidative 
Stress Response
Up-regulated genes (11) Actb, Dnaja3, Dnajb5, Dnajc1, Fos, Junb, Map2k4, Mapk14, Mapk8, Prkca, Ube2k
Down-regulated genes (3) Maf, Pik3r5, Slc35a2
 Neuregulin Signalling
Up-regulated genes (7) Adam17, Akt3, Dlg4, Frap1, Nrg3, Prkca, Rps6kb1
Down-regulated genes (1) Dcn
Neurotrophin/TRK Signalling
Up-regulated genes (6) Atf2, Fos, Map2k4, Mapk8, Ntrk2, Ntrk3
Down-regulated genes (1) Pik3r5
Toll-like Receptor Signalling
Up-regulated genes (5) Fos, Map2k4, Mapk14, Mapk8, Tollip
Table 2: Genes associated with IPA bio-functions and canonical pathways that are different from the GO categories shown 
in Table 1 (Continued)
genes have dual or multiple functions, for example,
Dnaja3 may function as a pro-apoptotic or as a survival-
enhancing protein, and it may also function as a nerve
cell process (neurite) growth-promoting gene [27]. The
same is true for Dyrk1a  whose absence stunts brain
growth, development and neurite elongation, yet its pres-
ence in excess, as it occurs in trisomy 21 (Down's syn-
drome), may retard neuronal growth and differentiation
[28,29]. We assume that in Glud1 mice, the primary role
of these genes is in enhancing neuronal growth and sur-
vival.
Stress response
Congruent with the overall up-regulation of stress
response, the NRF2-mediated oxidative stress response
pathway was also enriched with genes whose expression
was up-regulated. In addition to the Dnaja3  for Heat
Shock Protein 40, a related heat shock protein gene,
Dnajb5 (DnaJ [Hsp40] Homolog, Subfamily B, Member
5) was also significantly up-regulated in Tg compared
with wt mice (Table 2). Represented also in this pathway
were the genes for the transcription factors Fos and JunB,
which are known to be up-regulated following synaptic
activation of nerve cells, during learning of a new task,
and also under conditions of stress and neuronal damage
[30,31]. Increased expression of these factors may be sus-
tained for a long period of time following neuronal injury
[32]. Thus, their up-regulation in Tg mice may be consid-
ered as a trace of neuronal injury in the hippocampus,
possibly, as a result of chronic excess synaptic Glu release
in the Tg mice.
Protein mis-folding correction and degradation
Enhanced expression of genes for heat shock proteins
described above is not only indicative of a stress response
but also of an overall increase in protein refolding or tar-
geting for degradation. The category of Protein mis-fold-
ing correction & degradation (Table 2) included three
chaperone proteins distinct from the two heat shock pro-
teins (Dnaja3 and Dnajb5) described above. They wereWang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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Ahsa1 (Activator of Heat Shock 90 kDa Protein ATPase
Homolog 1), Ahsa2, and Dnajc1 (DnaJ [Hsp40] Homolog,
Subfamily C, Member 1). Heat Shock Protein 90 is
emerging as a very important chaperone in nerve cells
and its activity may determine the viability of neurons in
neurodegenerative diseases, such as Alzheimer's disease
[33]. The Activators of Heat Shock 90 kDa Proteins
(AHSA1 and AHSA2) are important regulators of the
activity of this class of chaperones [34] and may be indi-
cators of cellular response to excessive protein damage.
In addition to the over-expression of chaperone activa-
tor and chaperone protein genes in the Tg mice, six genes
involved in protein degradation were also part of the GO
category of Protein mis-folding correction & degradation.
These are the genes for Ubiquitin-Specific Peptidases,
including USP7, USP12, USP19, USP20, USP32 and
USP47, which degrade proteins following the attachment
of ubiquitin molecules to the proteins. In addition to
these Ubiquitin-Specific Peptidase genes, the genes for
Ubiquitin-Conjugating Enzymes, UBE2K and UBE3A,
which covalently attach ubiquitin molecules to proteins
destined for degradation, were also up-regulated in Tg
mice. The up-regulation of genes related to the correction
of mis-folded proteins (i.e., chaperone activity) and those
involved in the degradation of mis-folded proteins (i.e.,
ubiquitination and proteolysis), was indicative of a
heightened level of protein modification, defects in fold-
ing, and likely loss of function of proteins in the Glud1
hippocampus.
The transcriptomic data reported here on the up-regu-
lation of protein ubiquitination genes matched our previ-
ous observations of large accumulations of ubiquitinated
proteins in neurons of the same region in older Glud1
mice [14]. It should be noted that in this study, the tran-
scriptional up-regulation of protein ubiquitination genes
occurred by nine months of age, that is, it preceded the
accumulation and aggregation of ubiquitinated proteins
(not observed until the Tg mice were at sixteen months of
age [14]).
Chemokine and Toll-like receptor signalling
The significant up-regulation of two signalling pathways,
Chemokine signalling and  Toll-like receptor signalling,
also reveals increased cell responses to stress in the Tg
mice. Chemokines (short form of chemo-attractant
cytokines) are peptides that control inflammatory
responses in the immune system. In the brain, chemok-
ines also activate pathways that lead to cell survival, cell
adhesion, cell polarity, and synaptic transmission, that is,
they control many of the GO biological processes or IPA
bio-functions identified above (Tables 1 and 2) [35]. The
genes included in the Chemokine signalling pathway
(Table 2) were those of post-receptor signalling and
included genes for the focal adhesion kinases Ptk2b (Pro-
tein Tyrosine Kinase 2 Beta) and Ptk2 (Protein Tyrosine
Kinase 2), calcium-diacylglycerol-activated protein
kinase C alpha (Prkca), stress kinases Mapk8  and
Mapk14, and the calcium/calmodulin-dependent protein
kinases  Camk2a  and  Camk2b. Up-regulation of these
chemokine signalling pathway genes would be expected
to lead to activation of cell survival, growth, and synaptic
transmission in neurons [35]. Furthermore, some of the
same proteins are also involved in the Toll-like receptor
signalling pathway [36], especially the stress-activated
kinases Mapk8 and Mapk14.
Toll-like receptors are normally activated by macro-
molecules associated with bacteria or viral particles and
their activation leads to the innate immune responses in
the immune system. In the brain, Toll-like receptors may
be activated by macromolecules released from damaged
cells [36] and they may serve an important function in
clearing the extracellular space of potentially damaging
molecules, such as the amyloid beta that accumulates in
Alzheimer's disease [37]. Thus, stimulation of the
chemokine and Toll-like receptor signalling pathways in
brain cells may result from activation of stress signals
within neurons and from breakdown products released
following injury to neurons and glial cells. Overall, the
transcriptomic profile of the Glud1 Tg hippocampal cells
is a pattern of mounting defenses against cellular stress,
enhancing cell survival/growth/differentiation and, as
will be described below, preservation or re-establishing
normal neuronal function, especially synaptic transmis-
sion.
Amino acid metabolism functions
Noticeable was the absence of either up-regulated or
down-regulated genes that might be directly involved in
Glu-glutamine metabolism or mitochondrial metabolic
activity in Glud1  mice. The biological function amino
acid metabolism (Table 2) had several up-regulated genes
but these genes represented various types of kinases and
phosphatases, as well as proteins involved in cell growth,
differentiation, proliferation, and glycoside synthesis.
Only one gene directly related to amino acid metabolism,
Ass1 (Arginino-Succinate Synthetase 1), was down-regu-
lated (T able 2). This enzyme is part of the urea cycle, a
metabolic pathway that is also linked to Glu metabolism
and to GLUD1 activity in mitochondria [38]. Down-regu-
lation of this enzyme may represent neuronal compensa-
tory responses that would lead to reduced 2-oxoglutarate
and glutamate formation.
It is also particularly significant that one of the most
down-regulated genes in Glud1  mice was the gene
Slc17a6 (Solute Carrier Family 17, Member 6; or Vesicu-
lar Glutamate Transporter) (Table 2). This is the trans-
porter for Glu uptake and storage in synaptic vesicles of
neurons. The decreases in the vesicular Glu transporter
gene expression may represent another compensatoryWang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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response in neurons aimed at decreasing the amount of
Glu released at the synapse.
Transcriptomic changes on synapse formation, synaptic 
transmission, and neurite outgrowth and elongation
Neuronal growth, differentiation and preservation of syn-
aptic transmission were also reflected in the GO catego-
ries, IPA bio-functions and canonical pathways that were
enriched with genes differentially expressed in Tg mice.
The genes in these categories were mostly up-regulated
in the Tg mouse hippocampus and fell into one of the fol-
lowing biological processes, bio-functions or pathways:
Nervous system development,  Synaptic neurotransmis-
sion, Cytoskeleton and focal adhesion, Axonal guidance
signalling, Ephrin receptor signalling, Integrin signalling,
Neuregulin signalling, Neurotrophin/TRK signalling, and
Synaptic long-term potentiation. All of these categories
are related to growth of nerve processes, differentiation
of neurons, synapse formation, and synaptic transmis-
sion. Synaptic neurotransmission, one of the significantly
altered GO biological processes in Glud1 mice (Table 1),
contained two of the most up-regulated genes in Glud1
mice, those for the two Glu-activated synaptic receptors,
the  N-methyl-D- a s p a r t a t e  ( N M D A )  R e c e p t o r  S u b u n i t s
2A and 2B (Grin2A and Grin2B). The IPA pathway analy-
sis also identified Synaptic long term potentiation, a path-
way related to activation of synaptic transmission, as one
of the pathways that were significantly enriched with up-
regulated genes (including Grin2a and Grin2b) (Table 2).
The increased transcription for the two NMDA receptor
proteins might appear to be counterintuitive in neural
cells that are suffering from excess synaptic release of
Glu, because NMDA receptors are highly permeable to
Ca2+ and the excess Ca2+ entry is known to trigger oxida-
tive stress and neuronal death [9]. It is quite likely, how-
ever, that the increased expression of NMDA receptor
genes, especially Grin2b, was a reflection of the growth of
new synapses [39]. The observed increases in gene
expression for the synaptic membrane scaffold proteins
(Dlg1, Dlg2, and Dlg4), and a protein involved in synapse
strengthening (Arc, Activity-Regulated Cytoskeleton-
Associated Protein), also fit a pattern of new synapse
growth.
It was noted that gene expression for one type of
NMDA receptor proteins, that of Grin3a, was decreased
(down-regulated genes, Nervous system development,
Table 1). Because GRIN3A has a negative effect on syn-
apse formation [40], the decreases in Grin3a transcrip-
tion would fit with the hypothesis of neuronal
compensatory responses in Glud1 T g mice that lead to
increases in new synapse formation (i.e., through
decreases in a negative regulator of synapse formation).
The genes for several other Glu receptors were margin-
ally altered, with some down-regulated (Grm4  [Glu
Receptor, Metabotropic 4]: 1.27-fold) and Grm8  [Glu
Receptor, Metabotropic 8]: 1.37-fold), while others were
up-regulated (Gria1 [Glu Receptor, Ionotropic, AMPA 1]:
1.25-fold,  Gria3  [Glu Receptor, Ionotropic, AMPA 3]:
1.27-fold, and Grik2 [Glu Receptor, Ionotropic, Kainate
2]: 1.27-fold). The Glu receptor family contains many
members with divergent functions, differing kinetics of
activation, differing affinities for Glu, and different sites
of localization in regions of the brain or the synaptic
region of neurons [9]. The overall influence that the small
changes in expression of Gria's,  Grm's and Grik2  may
have on synaptic activity and neuronal integrity would be
difficult to predict.
Other important molecular determinants of axon, den-
drite and synapse growth included genes that were up-
regulated in Glud1 Tg mice and are listed under the cate-
gory of Nervous system development in Table 1. Among
them were the ephrin type A receptor genes Epha3,
Epha4, Epha6, and Epha7. Ephrin and the ephrin type A
receptors are known to be particularly important in the
development of the small protrusions that project from
the shafts of the dendritic processes of neurons, the
spines. Dendritic spines represent the post-synaptic ele-
ments of neuronal synapses and are extremely important
in the establishment and function of excitatory synapses.
Spine-associated synapses are involved in the physiologi-
cal processes related to learning and memory [41]. Spine
growth and synapse formation is also regulated by neu-
rotrophic factors, such as Brain-Derived Neurotrophic
Factor (BDNF), and the respective receptors for these
neurotrophic factors, such as NTRK2 and NTRK3
[42,43].
Cytoskeleton organization and formation of focal adhe-
sions also play important roles in the elongation of neu-
rites (axons or dendrites) and synapse formation. Gene
transcriptional activity for these cellular structures was
activated in the hippocampus of Tg mice as revealed by
the up-regulation of genes in the GO category of
Cytoskeleton and focal adhesion and in the bio-function
Cellular assembly and organization (Tables 1 and 2).
Included among these up-regulated genes were Anp32A
(Acidic Leucine-Rich Nuclear Phosphoprotein 32A), Egr2
(Early Growth Response 2) [44], Ptk2b, Pitpnm2 (coding
for Phosphatidylinositol Transfer Protein Neuronal
Membrane 2, a PTK2B-associated protein), and Enc1
(Ectodermal-Neural Cortex 1) [45]. Anp32A binds to a
microtubule-associated protein during neurite formation
or elongation [46], Egr2 regulates myelin sheath forma-
tion during axon development [44], Ptk2b and Pitpnm2
are involved in neurite elongation and synapse formation
[47], and Enc1 is involved in neuronal differentiation [45].
Many of the same genes also appeared under the GO cat-
egory and IPA bio-function of Nervous system develop-
ment (T able 1), as would be expected for gene productsWang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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that regulate the differentiation and growth of neurons
during early development.
The GO category of mRNA Processing and the IPA bio-
function of RNA Post-transcriptional modification con-
tained many up-regulated genes in the Tg mouse hip-
pocampus (Tables 1 and 2), including those for RNA
editing, RNA binding and transport, and pre-mRNA
splicing. Of particular interest among these genes was the
gene Syncrip, the protein product of which has been iden-
tified to be associated with dendrites of neurons where it
assists localized protein synthesis near synapses, possibly
in response to incoming stimuli in neurons [48,49]. The
up-regulation of Syncrip  and other mRNA processing
genes was indicative of increased trafficking and transla-
tion of mRNA's in the dendritic processes of Glud1 hip-
pocampal neurons. This up-regulation of gene expression
could be viewed as part of the pattern of neurite growth
and differentiation described above.
The transcriptomic changes on synapse formation and
neurite growth described in the present study of Glud1
Tg mice likely represent compensatory neuronal
responses to chronic mild Glu hyperactivity. It is, of
course, quite possible that the changes observed in 9-mo-
old mouse hippocampi were the result of abnormal neu-
ral circuit development in Tg mice during embryonic or
fetal development. Although such a scenario may be diffi-
cult to disprove, it should be pointed out that similar
transcriptomic analyses at a very early age (10 days post-
birth), in the same brain region as that analyzed in the
present study, showed that the hippocampus of Tg mice
a t this young age is very similar to tha t of wt mice in
terms of transcriptomic pattern (Wang, X., Hui, D.,
Michaelis, E.K., unpublished observations). These find-
ings would indicate that the moderate Glu hyperactivity
in the Glud1 Tg mice did not affect early brain develop-
ment. Therefore, while exposure to moderate Glu hyper-
activity during embryonic and fetal brain development
might lead to small alterations in neural circuitry, these
do not translate to the significant transcriptomic changes
reported here.
Gene network for neurite outgrowth and elongation
In order to elucidate how genes involved in neurite out-
growth and elongation interact to promote neuritogene-
sis in the Glud1  mouse brain, a gene network was
constructed for these genes and their partners (Figure 2).
Key players in this network include proteins involved in
focal adhesion of cell membranes to the extracellular
matrix, the focal adhesion kinases [47], activators of the
organization of cytoskeletal elements, the Rho GTPases,
and cytoskeletal element organizing-proteins, actin and
actin-associated proteins [43]. The information on gene-
gene interactions displayed in this network was based on
experimental evidence collected from previously pub-
lished literature reports.
During neurite outgrowth, extracellular growth and
guidance signals bind to their receptors on the distal end
of the neurites (i.e., the growth cone) and such binding
triggers downstream intracellular signal cascades that
induce neurite elongation. BDNF is one of such upstream
signals for neurite outgrowth and its transcription was
modestly up-regulated in the Tg animals. The genes for
two cell surface receptors of BDNF, Ntrk2  and  Ntrk3,
were significantly up-regulated. Other cell membrane
receptors in this network that interact with the extracel-
lular matrix during neurite elongation, include members
of the integrin family, and several of those genes were also
up-regulated. Integrins contain one α-subunit and one β-
subunit; genes coding for both subunits were up-regu-
lated, including Itga4, Itga8, and Itgb1.
Neuritogenesis requires efficient organization and reg-
ulation of the cytoskeleton in the growth cone region.
Actin filament re-organization can be brought about by
the actin-related protein complex 2/3 (Arpc2), which was
up-regulated in Glud1  mice. The expression of several
other genes whose products interact with actin filaments
or microtubules in the growth cone was also up-regulated
in Glud1 mouse hippocampus, including Actr3  (Actin-
Related Protein 3), Cttn (Cortactin), and Wasl (Wiskott-
Aldrich Syndrome-Like). PTK2B is also involved in actin
reorganization within the growing ends of neurites [50].
The up-regulation of genes in this network, collectively,
pointed in the direction of enhanced neurite outgrowth
and elongation in neurons of Glud1 brain. From the con-
structed network, it was also clear that PTK2B is one of
the most connected nodes and a central hub in the net-
work. In the dendrites of neurons, PTK2B protein is asso-
ciated with NMDA receptors and is involved in long-
term changes of synaptic activity [51-54]. The role of
NMDA receptors in synapse growth was described
above. As captured in the network, genes for partners of
PTK2B were also up-regulated in Glud1  hippocampal
neurons, including the protein kinase Prkca and the small
GTPase Rac1 (RAS-Related C3 Botulinum Substrate 1).
Immunohistochemical characterization of PTK2B and 
phospho-PTK2B levels in hippocampal neurons
To initiate neurite outgrowth and elongation, PTK2B
needs to be translocated from cytosol to the plasma
membrane. This translocation depends on its biochemi-
cal activation via auto-phosphorylation on Tyr 402
(PTK2BpY402), which is further dependent on the state
of Ca2+ signaling in neurons [55]. Excess [Ca2+]i in neu-
rons subjected to increased Glu activity in Glud1 mice,
may cause increases in PTK2BpY402 levels and lead to
subsequent PTK2B translocation to the plasma mem-
brane of neurons. To determine whether the events asso-Wang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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ciated with PTK2B-mediated neurite growth are indeed
more pronounced under the conditions of chronically
increased Glu activity in brain, we probed for evidence of
changes in the phosphorylation status of PTK2B, as well
as for changes in total protein levels of PTK2B in Glud1
mice.
Immunohistochemical labelling with anti-PTK2B pan-
antibodies and selective antibodies against the phospho-
rylated form of PTK2B was performed in 10-12 mo-old
mice, an age very close to the 9 mo-old mice used for the
microarray analyses. Labelling with the pan-antibodies to
PTK2B was strong in cell bodies and dendrites of hip-
pocampal CA1 pyramidal neurons of wt mice, and rela-
tively strong in Glud1 mice (e.g., Figure 3B, F). The cell
bodies and dendrites of neurons in the same sections
were also labelled by antibodies to microtubule-associ-
ated protein 2A (MAP2A), a protein that is known to be
expressed in neuronal cell bodies and dendrites. As we
reported previously [14], we observed lower levels of
MAP2A labelling in dendrites of the CA1 region of the
hippocampus of Glud1 mice as compared with the same
region in wt mice (e.g., Figure 3A, E). Densitometric anal-
yses of three fields of equal areas (3128 μm2/field) in the
CA1 stratum radiatum dendrite region from three hip-
pocampus sections from three Glud1 and three wt mice,
revealed significant decreases in MAP2A labelling in the
Tg mice (MAP2A = 26.51 ± 2.56, mean ± SEM, for Glud1;
37.83 ± 1.31, for wt mice; P = 0.029, One-way ANOVA,
pair-wise comparisons Student-Newman-Keuls). Yet,
despite the loss of labelling by MAP2A, PTK2B labelling
appeared to be well preserved in the dendrites of neurons
from the Glud1 mice as revealed by the lack of significant
differences in the same fields of the stratum radiatum of
the CA1 region from the same sections of Glud1 and wt
mouse hippocampus as those analyzed for MAP2A label-
ling (PTK2B = 43.72 ± 4.21, for Glud1; 41.32 ± .03, for wt;
n = 3 Tg and 3 wt mice; P = 0.69, ANOVA).
In addition to the PTK2B labelling in dendrites, the lev-
els of the phosphorylated form of PTK2B, PTK2BpY402,
were also well preserved in the CA1 region of the hip-
pocampus from Glud1 mice (Figure 3D, H). Once again,
the labelling by MAP2A antibodies (e.g., Figure 3C, G) in
these same sections from Glud1 mice was significantly
lower than that in wt mice (MAP2A = 22.29 ± 2.66 for
Glud1 mice; 32.88 ± 3.01, for wt mice; n = 3 Tg and 3 wt
mice; P = 0.039, ANOVA). In order to standardize the
labelling by PTK2BpY402 to the loss of MAP2A labelling
in dendrites of 10-12 mo-old Tg mice, we examined the
ratio of labelling (pixel density) by anti-PTK2BpY402 to
that of anti-MAP2A. This ratio was significantly higher in
the Glud1 mice (Glud1 = 1.22 ± 0.38; wt = 0.37 ± 0.02; n =
3 Tg and 3 wt mice; P = 0.046, ANOVA).
To determine whether these observations were consis-
tent across different ages of Tg and wt mice, we also
examined the same brain regions in three pairs of
younger (5 mo-old) and in three pairs of older (19-20 mo-
old) Glud1 and wt mice, using identical methodologies as
described above. Two-way ANOVA of the ratios of
PTK2BpY402 to MAP2A labelling (pixel density) in the
stratum radiatum of the CA1 region of 5, 10-12, and 19-
20 mo-old mice indicated a significant effect of the trans-
gene Glud1 when all ratios across all ages in Glud1 mice
were compared with those of the wt (P = 0.002). Pair-wise
comparisons (Student-Newman-Keuls method) revealed
significant differences in the ratios between Tg and wt
mice of 10-12 mo of age (P = 0.013) and of 19-20 mo of
age (P = 0.028). Although there was a trend of increasing
PTK2BpY402 to MAP2A ratios with advancing age in
both wt and Tg mice, there was no significant age effect
detected (P = 0.236). Overall, the immunohistochemical
characterization of PTK2B and phospho-PTK2B levels in
hippocampal neurons indicated that not only protein lev-
els but also biochemical activation (i.e., phosphorylation)
of PTK2B were significantly increased in the Tg mouse
hippocampus.
The  in situ labelling of PTK2B and PTK2BpY402
revealed the differential pattern of distribution of the
activated and non-activated forms of this key kinase.
Double immune labelling with MAP2A and PTK2B
showed a relatively smooth, continuous pattern of distri-
bution and co-localization of both proteins in dendrites,
although the PTK2B labelling appeared to be more super-
ficial than that of MAP2A in the dendrite shafts (Figure
4A). On the other hand, PTK2BpY402 was accumulated
in small or large puncta, some of them projecting off the
surface of CA1 neuronal dendrites (Figure 4B). These
phospho-PTK2B accretions might represent areas of
growth of new spines, new dendrite branches, or new
synapses.
Increased Ca2+ signalling, Ca2+ extrusion from cells, and Glu 
transport into glial cells
As mentioned above, Glu activation of its receptors leads
to increased Ca2+ influx into neurons and may initiate a
series of injurious events for neurons. In addition, the
processes of spine and synapse formation in brain neu-
rons are regulated by intracellular Ca2+ levels [56]. A rise
in intracellular Ca2+ concentration to a low level, leads to
elongation or growth of spines, whereas at higher levels
causes spine retraction. Since increased release of synap-
tic Glu would likely lead to hyper-activation of its recep-
tors and increased accumulation of intracellular Ca2+, it
might be expected that neurons of the Glud1 mice would
adapt to over-stimulation of Glu receptors by increasing
systems that either pump Ca2+ out of cells or sequester
Ca2+ into organelles. It is not surprising, therefore, that
the GO category of Ion transport and homeostasis and the
IPA canonical pathway of Ca2+ Signalling  included theWang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
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two key genes involved in Ca2+ transport out of cells,
Atp2b2 (ATPase, Ca2+ Transporting, Plasma Membrane
2) and Slc8a2 (Solute Carrier Family 8 [Sodium/Calcium
Exchanger], Member 2) (Tables 1 and 2). In addition to
the genes whose function is the regulation of intracellular
Ca2+ levels, there were several genes whose expression
was up-regulated and whose function is the modulation
o f  i n t r a c e l l u l a r  s i g n a l l i n g  m e d i a t e d  b y  C a 2+, such as
Camk2a, Camk2b, and Ppp3ca (Protein Phosphatase 3,
Catalytic Subunit, Alpha Isoform). The proteins coded by
these three genes have important functions in synaptic
transmission and long-term changes in synaptic activity.
Cells in the hippocampus of Glud1 mice made, appar-
ently, compensatory changes not only in the handling of
Ca2+ but also in the elimination of excess Glu released by
neurons in the brain of Tg mice. The major Glu trans-
porters that remove Glu from the brain synaptic cleft are
SLC1A2 (Solute Carrier Family 1 [Glial High Affinity
Glutamate Transporter], Member 2) and SLC1A3,
another glial high affinity Glu transporter. SLC1A2 is the
predominant transporter expressed in the plasma mem-
brane of hippocampus glial cells [57]. The transcription
of  Slc1a2  was highly (2.2-fold) up-regulated in Glud1
mice (Additional file 1). In addition, the transcription of
the gene Slc1a1  for the neuronal Glu transporter was
moderately (1.28-fold) increased in neurons of Glud1
mice. In separate studies, we found that the levels of the
SLC1A1 protein were increased in nerve ending particle
(synaptosome) prepared from the brains of 12-mo-old Tg
mice (1.39-fold) over those of wt mouse brain. Although
the differences between Glud1 and wt mice in gene and
protein levels were not large, transport of radioactive Glu
([3H]Glu) into nerve ending particles by, primarily, the
neuronal Glu transporters was significantly increased:
Vmax for [3H]Glu transport in Glud1 mouse particles was
5.7 ± 0.57 pmol•mg protein-1•min-1 and for the wt was 3.4
± 0.46 pmol•mg protein-1•min-1 (P = 0.013; n = 3). The
increased gene expression of Glu transporters together
with the increases in protein and transport activity were
congruent with the idea of a compensatory response in
Figure 2 Network of genes for neuritogenesis and neurite elongation. A neurite growth cone and genes related to neuritogenesis and neurite 
elongation are shown. These genes are grouped on the basis of their functions and these gene groups are marked by dotted-line boxes. The function 
groups in these boxes are: b1 - growth factor and ephrin receptors; b2 - Glu receptor and scaffolding genes; b3 - extracellular matrix interacting genes; 
b4 - actin-organizing genes; b5 - focal adhesion complex genes; and b6 - signal transduction (kinase, phosphatase, small GTPase-binding and activat-
ing) genes. The lines between genes indicate their interactions based on previously published experimental data (multiple interaction types, such as 
activation, inhibition, binding, etc., exist in the network). All genes in this network were up-regulated in the Glud1 neurons, indicative of neuronal ef-
forts to re-grow neurites in response to neurite loss observed in Tg mouse neurons. PTK2B, a major focal adhesion kinase, is a hub node in this network, 
indicating that it is one of the key gene players in neuritogenesis and neurite elongation.
b1
b2
b3
b4
b5
b6Wang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
Page 13 of 19
Tg mice that would clear synapses of excess extracellular
Glu in the brain.
Correlation of GeneChip data with quantitative PCR and 
immunoblot assays
To validate the GeneChip-derived gene expression data,
we conducted real-time quantitative PCR and immunob-
lot analyses of several key genes or their protein products.
The obtained results indicated a strong correlation of
these data with the data from microarray analyses (Figure
5). This correlation was significant, with the Pearson cor-
relation coefficient (r) being equal to 0.80 and the esti-
mated P value equal to 0.01.
Conclusions
In our previous studies, we have shown that over-expres-
sion of Glud1 and the resultant moderate excess Glu for-
mation and synaptic release, were correlated with
neuronal, dendritic spine, and nerve ending losses in
select regions of the brains of Tg mice, such as the CA1
region of the hippocampus. The selective nature of neu-
ronal damage in Glud1 mice probably contributes to their
survival into early aging, thus affording the opportunity
to examine the effects of Glud1  over-expression and
excess Glu formation and release on molecular and cellu-
lar pathways in brain across the lifespan.
Aging in human brain is associated with the selective
loss of synapses and neurons that are glutamatergic and
occurs in the absence of widespread loss of neurons or
synapses throughout the brain [19,21,58]. The neuronal
populations in human brain that are susceptible to injury
are some of the same populations of neurons that die in
increasing numbers with advancing age in Glud1 Tg mice
[14]. In this respect, the Glud1 Tg mice are, potentially, a
good model of the selective synapse and nerve cell losses
that are associated with advancing age in humans. Several
studies have shown that baseline extracellular levels of
Glu in brain, as well as the increases in Glu release follow-
ing depolarization of neurons, are 75 to 100% greater in
the brains of aged rodents as compared with those of
young organisms [59,60]. The age-associated increases in
extracellular Glu are thought to occur because of some
loss of function of Glu transporters during aging [61-64].
The in vivo effects of life-long increases in Glu forma-
tion and depolarization-induced release of Glu on neu-
ronal structure, function and adaptive molecular
responses of neurons and glia have not been character-
ized previously. Most studies have examined the cellular
and molecular responses of neurons to the toxicity pro-
duced following acute exposure to excess Glu or NMDA
[65,66]. As mentioned in a previous publication [14], the
neuronal damage caused by chronic Glu hyperactivity
under neuropathological conditions cannot be easily
reproduced by in vitro acute Glu treatments of neurons.
Acute exposure of neurons to Glu does not allow for the
Figure 4 Localization of PTK2B and PTK2BpY402 in dendrites of 
CA1 hippocampus neurons in Tg mice. Labelling with antibodies to 
PTK2B, PTK2BpY402, and MAP2A were performed exactly as in Figure 
3. The labelled sections were imaged using confocal microscopy and 
are shown as super-imposed images of PTK2B and MAP2A (A) or 
PTK2BpY402 and MAP2A (B). Sections were obtained from 20 mo-old 
mice. Enlarged images of dendrite regions from the stratum radiatum 
enclosed by white squares in A and B are presented below the respec-
tive images. Note the relatively uniform distribution of PTK2B in den-
drites of the CA1 region as compared to the large puncta of 
immunolabelling by anti-PTK2BpY402. Arrows point to the two types 
of labelling by anti-PTK2B and anti-PTK2BpY402 antibodies along the 
path of a dendrite in CA1 stratum radiatum. Bar: 10 μm.
Figure 3 Up-regulation of PTK2B detected by immunolabelling in 
the hippocampal CA1 region of Glud1 Tg mouse brain. Antibodies 
against PTK2B, phosphorylated PTK2B (PTK2BpY402), and MAP2A were 
used to label reactive neurons in the hippocampal CA1 region of 11 
mo Glud1 (A-D) and wt (E-H) mice. Immunolabelled sections were ex-
amined under confocal microscopy as described under Methods. 
Compared with hippocampus neurons in wt mouse, those in the 
Glud1 Tg mouse exhibited a substantial decrease in dendritic labelling 
by MAP2A (see also text). On the other hand, labelling by PTK2BpY402 
in Tg mouse hippocampus appeared to be higher than that observed 
in wt mice. After normalization of PTK2BpY402 immunoreactivity by 
expressing it as a ratio of PTK2BpY402 to MAP2A labelling, the levels of 
PTK2BpY402 were significantly higher in the Glud1 Tg neurons (see also 
text), a possible sign of increase in neurite growth in neurons of Tg 
mice. SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum. 
Scale bars: 10 μm.Wang et al. BMC Genomics 2010, 11:360
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determination of long-term adaptive responses and
r e p a i r  e f f o r t s  i n  a f f e c t e d  n e u r o n s .  I n  a d d i t i o n ,  a c u t e
exposure to high concentrations of Glu presents difficul-
ties in dissociating molecular responses representing
recovery from neuronal injury from those related to cell
death. Mechanistically, acute Glu treatments lead to
increased transport of ions (Ca2+  , Na+, K+  and Cl-)
[13,67,68], dysfunction in calcium-mediated signal trans-
duction [69-73], oxidative stress [74-77], cytoskeletal
alterations [78-80], changes in gene transcription through
altered activities of the transcription factors NF-κB, AP-1
or CREB [81-86], and cell death (including apoptosis,
necrosis and autophagy) [12,87-89]. Acute Glu treat-
ments also bring about significant changes in mitochon-
drial function, including decreased ATP synthesis,
depolarization, and structural collapse [90,91]. The mod-
erate, chronic increases in Glu levels and Glu release in
the  Glud1  T g  m i c e  a p p e a r  t o  p r o d u c e  m o l e c u l a r
responses that may counteract in neurons the adverse
effects of Glu hyperactivity, such as excess Ca2+ accumu-
lation, altered mitochondrial metabolism, energy deple-
tion, and neuronal death. Although we cannot totally
exclude the possibility of minor mitochondrial changes in
Glud1 Tg neurons, our transcriptomic analysis did not
show observable signs of significant mitochondrial dys-
function at the age probed (9 month).
Compared with acute Glu treatments, a distinctive
characteristic of chronic moderate Glu hyper-activity in
neurons of Glud1 Tg mice is the apparently compensa-
tory response of neurite regrowth and synapse formation.
Other responses, such as chronic inflammatory response,
are also unique to the Glud1 Tg mouse model. Because
chronic inflammation is an important aspect of brain
aging and many neurodegenerative conditions [92-94],
these responses in Glud1  Tg mice make this mouse a
more useful model of chronic brain neurodegenerative
conditions than the acute Glu treatment models of neu-
rotoxicity.
Selective neuronal damage in the brain of Glud1 mice
and the survival of these mice to an age greater than 21
months, distinguishes them from null mutant mice for
the Glu transporters or for the Tsc-1 gene. These other
animal models of high Glu concentrations in the extracel-
lular space are characterized by disruption of normal
brain development, lethal spontaneous seizures, neuronal
death in many regions of the brain, and dramatically
shortened lifespan [15-18]. Therefore, they are not suit-
able for probing the effects of chronic, moderate
increases in Glu synaptic release on neurons. To our
knowledge, there are no functional genomics studies that
h a v e  b e e n  p e r f o r m e d  o n  a n y  o f  t h e s e  a n i m a l  m o d e l s .
While it is possible that the toxicity to neurons caused by
tonically high levels of extracellular Glu in these animals
may share some commonalities with those reported here
for the Glud1 Tg mice, it is nevertheless evident that the
Glud1  Tg model is unique in capturing the effects of
moderate increases in Glu activity during brain aging
without the extensive and early developmental neuropa-
thology observed in other animal models.
In summary, chronic exposure of brain neurons and
glial cells to increased extracellular release of the neu-
rotransmitter Glu led to up-regulation of a constellation
of genes in hippocampal cells. The main functional cate-
gories and molecular pathways of the genes that were
over-expressed in the Glud1  mice were those of cell
responses to oxidative stress, cell injury, and inflamma-
tion, as well as those of nervous system development,
neurite growth, and synaptic transmission. The overall
transcriptomic profile of Glud1 mice was indicative of
apparent compensatory responses that were either pro-
tective against stress or promoting neuronal recovery. A
key gene in the pathway of neurite growth and synapse
formation was identified in this study as being that of the
kinase Ptk2b. We determined that the gene and the acti-
vated form of this protein, the phosphorylated PTK2B,
were up-regulated in Glud1 Tg hippocampal neurons that
are normally susceptible to the injury that results from
hyper-glutamatergic activity. The Glud1 over-expressing
mouse does show an acceleration in the rate of aging-
associated changes observed in normal brain [14], yet
Figure 5 Correlation of GeneChip data with real-time quantita-
tive PCR or immunoreactivity data of nine important genes with 
significantly altered expression in the Glud1 mice. To validate the 
GeneChip data, confirmatory data were collected by both real-time 
quantitative PCR and Western blot analyses. Three replicate measure-
ments were performed on each gene (or protein) and the mean value 
is shown here. Real-time quantitative PCR was used for the measure-
ments of Arhgap12, Arhgef2, Arpc2 and Epha4, while Western blots 
were used for the products of Dlg4, Gria1, Grin2a, Grin2b and Ptk2b. The 
Pearson correlation coefficient (r) between the GeneChip and confir-
matory data, and the estimated p value, are shown at the bottom. The 
best-fit linear regression line (solid line) and the estimated 95% confi-
dence limits (dashed lines) are also shown.Wang et al. BMC Genomics 2010, 11:360
http://www.biomedcentral.com/1471-2164/11/360
Page 15 of 19
some of the neurobiological functions and molecular
pathways altered in the transgenic mouse brain differ sig-
nificantly from those altered during aging. Whereas
Stress response, DNA repair,  Inflammation, and Tran-
scription categories of genes are up-regulated in Glud1
mice and the aged brain, the categories of Synaptic trans-
mission, Ca2+ homeostasis & signalling, Vesicular trans-
port, and Cell signalling are up-regulated in Glud1 mice
but down-regulated in the aging human brain [95]. We
conclude, therefore, that gene expression in 9 mo-old
Glud1  mice may reflect two molecular and cellular
responses to Glu hyper-activity, an accelerated form of
aging at the cellular and transcriptomic level, and com-
pensatory responses to Glu hyper-activity that lead to
neuronal recovery of growth and function. The present
study has focused on the molecular pathways that may be
affected by the over-expression of Glud1 in neurons in
young adult mice. Future studies will explore changes in
these molecular patterns with advancing age.
Methods
Animals used for transcriptomic analyses
Nine month-old male Glud1 T g mice were used in the
transcriptomic study. The procedure for generating the
Tg mice was described in detail previously [14]. Age-
matched, wild-type, male mice of the same genetic back-
ground (C57BL/6) were used as the controls. A total of
three Glud1 Tg and three control mice were used. All ani-
mals were housed in a 12 hour light/dark cycle with food
and water ad libitum. All animal procedures were per-
formed in accordance with guidelines established by the
University of Kansas IACUC. Briefly , the animals were
anesthetized, hippocampi dissected out from the brains,
flash frozen in liquid nitrogen, and stored at -80°C prior
to total RNA extraction.
RNA extraction and microarray data generation
Total RNA samples were extracted from the dissected
hippocampi using the Qiagen RNeasy® Mini Kit (Qiagen,
Valencia, CA, USA). To prepare targets for subsequent
GeneChip hybridization, One-Cycle cDNA Synthesis Kit
from Affymetrix (Santa Clara, CA, USA) was used and
the manufacturer's instructions were followed. The
Affymetrix GeneChip Mouse Genome 430 2.0 arrays,
which are designed to interrogate expression of over
39,000 mouse gene transcripts, were used for the hybrid-
ization. Subsequent washing and staining steps were per-
formed on a GeneChip Fluidics Station 450 and the chips
were scanned on a GeneChip Scanner 3000 (Affymetrix).
Instrument control and data collection were carried out
using GeneChip Operating Software (GCOS, ver 1.1.1).
In order to minimize experimental variability, all steps in
tissue dissection, RNA isolation and microarray opera-
tion were performed by a single investigator. The quality
and quantity of the original RNA samples and of the
cRNA probes generated for array hybridization were
determined with an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA), and a NanoDrop ND-
1000 Spectrophotometer (Thermo Scientific, Wilming-
ton, DE, USA). The microarray data generated from all
chips met the quality control criteria set by Affymetrix,
including low background and noise, positive detection of
QC probesets such as bioB, percentage of genes called
present in normal range (generally between 40-60%),
similar scaling factors across all chips, and acceptable 3'/
5' ratios. All microarray data were deposited in NCBI's
Gene Expression Omnibus (GEO), with series accession
number GSE11419.
Transcriptomic data analysis
The generated GeneChip CEL data were normalized by
the Robust Multiarray Average (RMA) algorithm [96].
Prior to the identification of genes showing significant
differential expression patterns, probesets that were
detected to be non-expressed, i.e., those with absence
calls, were filtered out and excluded from further analy-
sis. In addition, probesets that are designed solely for the
purpose of chip quality control (monitoring hybridization
target preparation and array hybridization), i.e., those
with prefix AFFX, were also filtered out. These filtering
steps were employed in order to reduce the number of
comparisons in subsequent analyses and thus reduce the
FDR. SAM (Significance Analysis of Microarrays), a
supervised learning software for genomic expression data
mining [97], was used to identify genes showing signifi-
cant differential expression patterns. Cyber-T analysis
[98] was used to confirm expression patterns of differen-
tial genes identified by SAM. Three criteria were used to
determine statistically significant differential expression
of genes between Tg and wt mice: Bayesian P value ≤ 0.05,
fold change ≥ 1.3, and FDR ≤ 1%. Hierarchical clustering
of the samples (condition tree) was performed using the
software GeneSpring GX ver7.3 (Agilent Technologies).
Gene Ontology (GO) analysis was conducted with GO-
elite, a MAPPFinder analysis tool [99]. The gene annota-
tion and GO-elite databases used for the analyses were
those of March 2008. Hypergeometric distribution was
used and a Z score > 1.96 or < -1.96 and a permute P
value < 0.05, were considered to be statistically signifi-
cant. Comparative analyses on bio-function and canoni-
cal pathways of the identified differentially expressed
genes were conducted using IPA (Ingenuity Systems,
Redwood City, CA, USA). For these analyses, Fischer's
exact test was used to calculate the P values. The recon-
struction of the neuritogenesis network was performed
using Pathway Studio (Ariadne Genomics, Rockville, MD,
USA). The ResNet database used for the reconstruction
was of January 2008.Wang et al. BMC Genomics 2010, 11:360
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Real-time quantitative PCR
The remainder of the hippocampal total RNA extracts
not used in the microarray studies was used for real-time
PCR. The RNA was reverse-transcribed to cDNA using
oligo(dT) primers. Taqman Gene Expression Assay
reagents (Applied Biosystems, Foster City, CA, USA)
were employed in the real-time PCR using an Applied
Biosystems 7500 Fast Real-Time PCR System in fast
mode. The PCR thermal cycling conditions were: an ini-
tial step of 20 sec at 95°C, followed by 40 cycles of 95°C
for 3 sec, and 60°C for 30 sec. Quantification of the target
genes was based on the relative standard curve method
[100]. The measurements were standardized against the
gene for neuron-specific enolase (Nse, or Eno2) as its
ratio between the Glud1 and wild-type mice was the one
closest to unity (0.98).
Immunoblot assays
For immunoblot studies, proteins were first extracted
from hippocampi dissected from the same animals as
those used for the microarray study, i.e., three 9-mo-old
Glud1 Tg and three age-matched wt male mice. The pro-
tein extracts were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting as described previously [101]. Anti-
DLG4, -GRIA1, -GRIN2A, -GRIN2B, and -PTK2B anti-
bodies were used at 1:1000 to 1:2000 dilutions. Relative
levels of expression were estimated by densitometry.
Immunohistochemical analysis of PTK2B and PTK2BpY402 
levels
Three pairs of wt and Tg male mice from three age groups
were used for the immunohistochemical studies (total 9
wt and 9 Tg mice). The age groups were: 5 mo-old, 10-12
mo-old, and 19-20 mo-old wt and Tg mice. Brains from
these animals were dissected out and immersion-fixed in
4% paraformaldehyde-phosphate buffered saline (PBS)
for 72 hr at 4°C. Following fixation, the brains were cryo-
protected (incubation in 30% sucrose/PBS), frozen by
exposure for 30 sec to 2-methyl-butane at liquid N2 tem-
peratures, and coronal sections (24 μm thickness) cut in a
cryotome. The sections were then transferred onto gela-
tin-coated glass slides. The sections were blocked with
3% (w/v) gelatin in PBS (1 hr at 37°C), treated with 0.1%
Triton X-100 in PBS (15 min at 23°C), and reacted (over-
night at 4°C, then 1 hr at 23°C) with the respective pri-
mary antibodies. Polyclonal PTK2B antibody was used at
a dilution of 1:300 and polyclonal anti-PTK2BpY402 at
1:250. Each section was also exposed to monoclonal anti-
MAP2A at 1:1,000 dilution. Following rinsing of the sec-
tions in PBS, they were incubated (2 hr at 37°C) with fluo-
rescent dye-labelled secondary antibodies and processed
as described [101,102]. The sections were rinsed in PBS
(5 min at 23°C), mounted in 70% glycerol, and viewed
using a Zeiss LSM 510 confocal microscope [101]. For
densitometric measurements and quantification of pixel
densities of anti-PTK2B, anti-PTK2BpY402, and anti-
MAP2A immunolabelled sites in neuronal dendrites in
the stratum radiatum of the hippocampus CA1 region,
measurements of pixel densities were obtained from
within three equal-sized areas (3128 μm2) from three sec-
tions from each mouse hippocampus using the Photo-
shop program. All data were analyzed using either One-
Way or Two-Way ANOVA with post hoc multiple pair-
wise comparisons (Student-Newman-Keuls method). Sig-
nificance levels were P = 0.05.
Additional material
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